Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL
Authors
Keywords
-
Journal
BLOOD
Volume 137, Issue 6, Pages 788-800
Publisher
American Society of Hematology
Online
2021-02-13
DOI
10.1182/blood.2019004713
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Organoid Polymer Functionality and Mode of Klebsiella pneumoniae Membrane Antigen Presentation Regulates Ex Vivo Germinal Center Epigenetics in Young and Aged B Cells
- (2020) Pamela L. Graney et al. ADVANCED FUNCTIONAL MATERIALS
- Secondary Metabolites from the Fungus Dictyosporium sp. and Their MALT1 Inhibitory Activities
- (2019) Trong D. Tran et al. JOURNAL OF NATURAL PRODUCTS
- Germinal center‐derived lymphomas: The darkest side of humoral immunity
- (2019) Coraline Mlynarczyk et al. IMMUNOLOGICAL REVIEWS
- Quinoline and thiazolopyridine allosteric inhibitors of MALT1
- (2019) David A. Scott et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Role of PI3K Inhibition in Lymphoid Malignancies
- (2019) Gottfried von Keudell et al. Current Hematologic Malignancy Reports
- Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment
- (2019) Ryan M. Young et al. IMMUNOLOGICAL REVIEWS
- Antiapoptotic properties of MALT1 protease are associated with redox homeostasis in ABC‐DLBCL cells
- (2019) Leqing Zhu et al. MOLECULAR CARCINOGENESIS
- N -aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity
- (2018) Achim Schlapbach et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A multiprotein supercomplex controlling oncogenic signalling in lymphoma
- (2018) James D. Phelan et al. NATURE
- Assembly mechanism of the CARMA1–BCL10–MALT1–TRAF6 signalosome
- (2018) Liron David et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth
- (2018) Lorena Fontán et al. JOURNAL OF CLINICAL INVESTIGATION
- Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling
- (2018) Mélanie Juilland et al. Frontiers in Immunology
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells
- (2017) Katharina Essig et al. IMMUNITY
- The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma
- (2017) Jiao Li et al. INTERNATIONAL JOURNAL OF CANCER
- PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors
- (2017) Anella Yahiaoui et al. PLoS One
- Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
- (2017) Xiaohong Zhao et al. Nature Communications
- Mucosa-associated lymphoid tissue lymphoma translocation 1 as a novel therapeutic target for rheumatoid arthritis
- (2017) Chang Hoon Lee et al. Scientific Reports
- B-cell receptor–driven MALT1 activity regulates MYC signaling in mantle cell lymphoma
- (2016) Beiying Dai et al. BLOOD
- Targeting mTOR for the treatment of B cell malignancies
- (2016) Jong-Hoon Scott Lee et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
- (2016) Raju V. Pusapati et al. CANCER CELL
- MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation
- (2016) Wen Liu et al. Oncotarget
- Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling
- (2016) Elizabeth Allen et al. Cell Reports
- Ex vivo engineered immune organoids for controlled germinal center reactions
- (2015) Alberto Purwada et al. BIOMATERIALS
- AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
- (2015) Moshe Elkabets et al. CANCER CELL
- Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation
- (2015) Frédéric Bornancin et al. JOURNAL OF IMMUNOLOGY
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
- (2015) Wyndham H Wilson et al. NATURE MEDICINE
- Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma
- (2015) Daniel Nagel et al. Oncotarget
- Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation
- (2015) Roybel R Ramiscal et al. eLife
- MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses
- (2015) Jong W. Yu et al. PLoS One
- Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma
- (2015) Scott A. Ezell et al. Oncotarget
- Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
- (2014) L. Nathan Tumey et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity
- (2014) Maike Jaworski et al. EMBO JOURNAL
- High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells
- (2014) Lesley A. Mathews Griner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Architecture of the CARMA1/Bcl10/MALT1 Signalosome: Nucleation-Induced Filamentous Assembly
- (2013) Qi Qiao et al. MOLECULAR CELL
- MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
- (2012) Lorena Fontan et al. CANCER CELL
- Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL
- (2012) Daniel Nagel et al. CANCER CELL
- TNFR-Associated Factor 2 Deficiency in B Lymphocytes Predisposes to Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in Mice
- (2012) G. Perez-Chacon et al. JOURNAL OF IMMUNOLOGY
- Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
- (2010) Sonali M. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
- (2010) T E Witzig et al. LEUKEMIA
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Critical role of PI3K signaling for NF- B-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells
- (2010) B. Kloo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of MALT1 protease activity is selectively toxic for activated B cell–like diffuse large B cell lymphoma cells
- (2009) Uta Ferch et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
- (2009) M. Breuleux et al. MOLECULAR CANCER THERAPEUTICS
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
- (2009) S. Hailfinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The proteolytic activity of the paracaspase MALT1 is key in T cell activation
- (2008) Fabien Rebeaud et al. NATURE IMMUNOLOGY
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly parallel identification of essential genes in cancer cells
- (2008) B. Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search